CUSIP 15117K103SPON ADSCLLSQ4 2025
21 filings · latest Dec 12, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | B Group, Inc. | 3.28M | $15.88M |
| 2 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 3.18M | $15.38M |
| 3 | Long Focus Capital Management, LLC | 2.79M | $13.49M |
| 4 | Blackrock, Inc. | 384.3K | $1.86M |
| 5 | Nomura Asset Management International Inc. | 226.9K | $1.10M |
| 6 | Marshall Wace, LLP | 178.5K | $863.8K |
| 7 | Citadel Advisors LLC | 95.4K | $461.9K |
| 8 | Morgan Stanley | 87.2K | $421.9K |
| 4 | Jan 24, 2025 | Astrazeneca PLC | 13D/A | 44.0% | — | SEC |
| 5 | May 21, 2024 | Bpifrance Participations SA | 13D/A | 5.9% | 5.87M | SEC |
| 6 | Feb 14, 2024 | Long Focus Capital Management, LLC | 13G/A | 6.3% | 4.49M | SEC |
| 7 | Feb 14, 2024 | Pfizer Inc | 13G/A | 3.9% | 2.79M | SEC |
| 8 | Dec 5, 2023 | Baillie Gifford & Co | 13G/A | 3.1% | 2.19M | SEC |
| 9 | Nov 16, 2023 | Astrazeneca PLC | 13D/A | 22.4% | 16.00M | SEC |
| 10 | Nov 13, 2023 | Bpifrance Participations SA | 13D/A | 8.2% | 5.87M | SEC |
See the full Schedule 13D/13G history for Cellectis S A.
Unlock full history| 9 |
| Lpl Financial LLC |
| 84.8K |
| $410.4K |
| 10 | Susquehanna International Group, LLP | 52.4K | $253.7K |